Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Stock Forecast 2025 - AI Price Prediction & Analysis

ARROWHEAD PHARMACEUTICALS, INC. (ARWR) AI Stock Price Forecast & Investment Analysis

ARROWHEAD PHARMACEUTICALS, INC. Stock Price Chart and Technical Analysis

Loading ARROWHEAD PHARMACEUTICALS, INC. interactive price chart and technical analysis...

ARROWHEAD PHARMACEUTICALS, INC. (ARWR) - Comprehensive Stock Analysis & Investment Research

Deep dive into ARROWHEAD PHARMACEUTICALS, INC.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about ARROWHEAD PHARMACEUTICALS, INC., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For ARROWHEAD PHARMACEUTICALS, INC.: ARROWHEAD PHARMACEUTICALS, INC. operates in the Life Sciences sector, establishing it as a mid-cap growth opportunity.

ARROWHEAD PHARMACEUTICALS, INC. (Stock Symbol: ARWR) is a leading company in the Life Sciences sector , specifically operating within the Pharmaceutical Preparations industry.

The organization employs approximately 109 professionals worldwide .

The company has established itself as a growing mid-cap opportunity with strong fundamentals.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing ARROWHEAD PHARMACEUTICALS, INC.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For ARROWHEAD PHARMACEUTICALS, INC.: With $572M in annual revenue and -5326.5% net margin, the company demonstrates developing profitability.

Annual Revenue: $572 million generating a -5326.5% net profit margin .

Market Capitalization: $5383 million - Classified as a mid-cap growth stock with balanced risk-reward profile.

Return on Equity (ROE): -24.9% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for ARROWHEAD PHARMACEUTICALS, INC. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For ARROWHEAD PHARMACEUTICALS, INC.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for ARROWHEAD PHARMACEUTICALS, INC. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: ARROWHEAD PHARMACEUTICALS, INC.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For ARROWHEAD PHARMACEUTICALS, INC.: Market positioning analysis based on available financial and operational metrics.

ARROWHEAD PHARMACEUTICALS, INC. strategically competes in the highly dynamic Pharmaceutical Preparations marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share .

The company maintains a healthy 7.3% gross margin, indicating strong pricing power and operational efficiency.

ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for ARROWHEAD PHARMACEUTICALS, INC. stock analysis.

Loading ARROWHEAD PHARMACEUTICALS, INC. comprehensive fundamental analysis and insider trading data...

Deep dive into ARROWHEAD PHARMACEUTICALS, INC.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if ARROWHEAD PHARMACEUTICALS, INC. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For ARROWHEAD PHARMACEUTICALS, INC.: With a P/E ratio of -4.73, the market sees the stock as potentially undervalued.

P/E Ratio -4.73x
P/B Ratio 10.31x
Market Cap $5383M
EPS $-1.20
Book Value/Share $3.78
Revenue/Share $4.15
FCF/Share $-0.88
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently ARROWHEAD PHARMACEUTICALS, INC. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For ARROWHEAD PHARMACEUTICALS, INC.: An ROE of -24.9% indicates room for improvement in shareholder value creation.

ROE -24.9%
ROA -15.3%
ROIC -23.6%
Gross Margin 7.3%
Operating Margin -5340.6%
Net Margin -5326.5%
EBT Margin -42.4%
Tax Rate 0.3%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess ARROWHEAD PHARMACEUTICALS, INC.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For ARROWHEAD PHARMACEUTICALS, INC.: A current ratio of 3.01 indicates strong liquidity.

Current Ratio 3.01x
Quick Ratio 2.90x
D/E Ratio 0.05x
Financial Leverage 1.56x
Working Capital $282M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal ARROWHEAD PHARMACEUTICALS, INC.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For ARROWHEAD PHARMACEUTICALS, INC.: Free cash flow of $-75M indicates cash challenges that need attention.

Operating Cash Flow $-52M
Free Cash Flow $-75M
Capital Spending $-23M
FCF/Sales -28.5%
CapEx/Sales 8.6%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively ARROWHEAD PHARMACEUTICALS, INC. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For ARROWHEAD PHARMACEUTICALS, INC.: An asset turnover of 0.36x suggests room for improvement in asset utilization.

Asset Turnover 0.36x
Receivables Turnover 231.9x
Fixed Assets Turnover 4.1x
Days Sales Outstanding 2 days
Understanding Financial Statement Data

What these metrics mean: Key figures from ARROWHEAD PHARMACEUTICALS, INC.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For ARROWHEAD PHARMACEUTICALS, INC.: With annual revenue of $572M, ARROWHEAD PHARMACEUTICALS, INC. demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $572M
R&D Expense $18M
SG&A Expense $44M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 59%
Cash & Short-term Investments 57%
Total Liabilities 36%
Short-term Debt 0%
Accounts Receivable 0%
Dividend & Shareholder Information
Shares Outstanding 138M
Growth Metrics (YoY)
EPS Growth -22.0%

Latest ARROWHEAD PHARMACEUTICALS, INC. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting ARROWHEAD PHARMACEUTICALS, INC. (ARWR) stock price and investment outlook.

📰 We are currently updating our news feed for ARROWHEAD PHARMACEUTICALS, INC.. Check back soon for the latest market analysis and company updates.

ARROWHEAD PHARMACEUTICALS, INC. Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of ARROWHEAD PHARMACEUTICALS, INC. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AARD Unlock Forecast - 30 Days FREE Trial $278M x 2.0x
ABBV Unlock Forecast - 30 Days FREE Trial $402014M 106.8x 0.0x
ABCL Unlock Forecast - 30 Days FREE Trial $1729M -5.3x 1.7x
ABT Unlock Forecast - 30 Days FREE Trial $223232M 16.0x 4.4x
ABUS Unlock Forecast - 30 Days FREE Trial $845M -8.3x 10.2x
ACAD Unlock Forecast - 30 Days FREE Trial $3477M 15.7x 4.2x
ACET Unlock Forecast - 30 Days FREE Trial $82M -0.4x 0.6x
ACRS Unlock Forecast - 30 Days FREE Trial $206M -4.5x 1.6x
ACRV Unlock Forecast - 30 Days FREE Trial $57M -2.8x 0.4x
ACTU Unlock Forecast - 30 Days FREE Trial $153M x -24.1x
ACUT Unlock Forecast - 30 Days FREE Trial $25M x x
ACXP Unlock Forecast - 30 Days FREE Trial $10M -0.8x 2.8x
ADAG Unlock Forecast - 30 Days FREE Trial $104M x 2.7x
ADCT Unlock Forecast - 30 Days FREE Trial $459M -9.2x -1.3x
ADIL Unlock Forecast - 30 Days FREE Trial $8M -0.1x 1.4x
ADTX Unlock Forecast - 30 Days FREE Trial $1M 0.0x 0.1x
AGIO Unlock Forecast - 30 Days FREE Trial $2414M 3.7x 1.8x
AIMD Unlock Forecast - 30 Days FREE Trial $17M -0.4x 1.5x
AKRO Unlock Forecast - 30 Days FREE Trial $4288M -8.7x 4.2x
AKTX Unlock Forecast - 30 Days FREE Trial $52184M -2.0x 2038.0x
ALDX Unlock Forecast - 30 Days FREE Trial $316M -5.1x 5.7x
ALLR Unlock Forecast - 30 Days FREE Trial $21M -0.2x 1.7x
ALMS Unlock Forecast - 30 Days FREE Trial $294M x 0.6x
ALNY Unlock Forecast - 30 Days FREE Trial $63009M -224.3x 251.4x
ALT Unlock Forecast - 30 Days FREE Trial $326M -5.7x 2.0x
ALXO Unlock Forecast - 30 Days FREE Trial $80M -0.4x 1.3x
ALZN Unlock Forecast - 30 Days FREE Trial $7M -0.1x 1.3x
AMPH Unlock Forecast - 30 Days FREE Trial $1107M 8.2x 2.5x
AMRN Unlock Forecast - 30 Days FREE Trial $8158M -4.5x 17.6x
AMRX Unlock Forecast - 30 Days FREE Trial $3172M 939.8x 0.0x
ANEB Unlock Forecast - 30 Days FREE Trial $109M -4.3x 8.1x
ANIP Unlock Forecast - 30 Days FREE Trial $1840M 103.2x 4.2x
ANNX Unlock Forecast - 30 Days FREE Trial $467M -4.1x 2.4x
ANRO Unlock Forecast - 30 Days FREE Trial $165M x 1.3x
APLS Unlock Forecast - 30 Days FREE Trial $3080M -13.6x 19.7x
APRE Unlock Forecast - 30 Days FREE Trial $9M -1.2x 0.7x
APUS Unlock Forecast - 30 Days FREE Trial $23M x 2.4x
AQST Unlock Forecast - 30 Days FREE Trial $703M -10.7x -6.9x
ARCT Unlock Forecast - 30 Days FREE Trial $561M -7.0x 2.4x
ARDX Unlock Forecast - 30 Days FREE Trial $1192M -21.3x 8.5x
ARTL Unlock Forecast - 30 Days FREE Trial $3M -0.7x 42.0x
ARVN Unlock Forecast - 30 Days FREE Trial $697M -4.8x 1.1x
ARWR Unlock Forecast - 30 Days FREE Trial $5383M -4.7x 10.3x
ASBP Unlock Forecast - 30 Days FREE Trial $17M x x
ASMB Unlock Forecast - 30 Days FREE Trial $226M -1.5x 12.5x
ASRT Unlock Forecast - 30 Days FREE Trial $77M -0.2x 0.8x
ATAI Unlock Forecast - 30 Days FREE Trial $1173M -4.4x 8.2x
ATXI Unlock Forecast - 30 Days FREE Trial $2M -9.5x 0.6x
ATXS Unlock Forecast - 30 Days FREE Trial $676M -4.7x 2.6x
AUPH Unlock Forecast - 30 Days FREE Trial $1540M 25.4x 4.6x
AVBP Unlock Forecast - 30 Days FREE Trial $731M x 2.9x
AVDL Unlock Forecast - 30 Days FREE Trial $1422M -10.2x 15.7x
BBIO Unlock Forecast - 30 Days FREE Trial $10520M -11.6x -5.4x
BCAX Unlock Forecast - 30 Days FREE Trial $996M x 2.3x
BCTX Unlock Forecast - 30 Days FREE Trial $22M -1.7x 1.3x
BCYC Unlock Forecast - 30 Days FREE Trial $566M -6.0x 0.9x
BEIGF Unlock Forecast - 30 Days FREE Trial $23196M x 6.2x
BFRG Unlock Forecast - 30 Days FREE Trial $14M -2.9x 6.5x
BFRI Unlock Forecast - 30 Days FREE Trial $10M -0.1x 17.9x
BHC Unlock Forecast - 30 Days FREE Trial $2220M 22.7x -2.0x
BHVN Unlock Forecast - 30 Days FREE Trial $1691M -4.6x 12.6x
BIOA Unlock Forecast - 30 Days FREE Trial $186M x 0.6x
BIVI Unlock Forecast - 30 Days FREE Trial $4M -0.6x 0.2x
BLTE Unlock Forecast - 30 Days FREE Trial $2560M x 28.3x
BMEA Unlock Forecast - 30 Days FREE Trial $88M -1.6x 3.2x
BMRN Unlock Forecast - 30 Days FREE Trial $10166M 15.5x 1.7x
BMY Unlock Forecast - 30 Days FREE Trial $88472M 17.5x 5.1x
BMYMP Unlock Forecast - 30 Days FREE Trial $1498665M 296.8x 86.0x
BOLD Unlock Forecast - 30 Days FREE Trial $31M -15.1x 0.3x
BYSI Unlock Forecast - 30 Days FREE Trial $71M x -3.1x
CALC Unlock Forecast - 30 Days FREE Trial $45M 0.4x 7.4x
CAMP Unlock Forecast - 30 Days FREE Trial $59M -0.1x 1.5x
CANF Unlock Forecast - 30 Days FREE Trial $1984M x 474.1x
CARM Unlock Forecast - 30 Days FREE Trial $2M -0.7x 0.0x
CASI Unlock Forecast - 30 Days FREE Trial $27M -1.4x 14.6x
CDT Unlock Forecast - 30 Days FREE Trial $8M -0.7x 2.4x
CING Unlock Forecast - 30 Days FREE Trial $18M -0.6x 3.3x
CLCS Unlock Forecast - 30 Days FREE Trial $17M x x
CLNN Unlock Forecast - 30 Days FREE Trial $80M -7.3x -6.9x
CLSD Unlock Forecast - 30 Days FREE Trial $298M -2.0x -0.7x
CLYM Unlock Forecast - 30 Days FREE Trial $131M -1.4x 0.7x
CMMB Unlock Forecast - 30 Days FREE Trial $1374M 10.9x 141.7x
CMPS Unlock Forecast - 30 Days FREE Trial $610M 0.0x 3.8x
CNSP Unlock Forecast - 30 Days FREE Trial $5M 0.0x 0.4x
CNTA Unlock Forecast - 30 Days FREE Trial $3047M -11.0x 8.8x
CNTB Unlock Forecast - 30 Days FREE Trial $96M x 1.4x
CNTX Unlock Forecast - 30 Days FREE Trial $129M -1.5x 1.6x
COGT Unlock Forecast - 30 Days FREE Trial $1841M -3.7x 11.9x
COYA Unlock Forecast - 30 Days FREE Trial $106M -6.8x 3.8x
CPHI Unlock Forecast - 30 Days FREE Trial $6M -0.2x 0.9x
CPIX Unlock Forecast - 30 Days FREE Trial $51M -4.5x 1.8x
CPRX Unlock Forecast - 30 Days FREE Trial $2494M 12.0x 2.9x
CRMD Unlock Forecast - 30 Days FREE Trial $760M 14.9x 3.4x
CRNX Unlock Forecast - 30 Days FREE Trial $3959M -15.9x 3.4x
CRVO Unlock Forecast - 30 Days FREE Trial $66M -0.7x 2.0x
CRVS Unlock Forecast - 30 Days FREE Trial $525M -13.7x 6.5x
CTMX Unlock Forecast - 30 Days FREE Trial $349M 7.3x 2.9x
CTOR Unlock Forecast - 30 Days FREE Trial $122M 3.9x 3.8x
CTXR Unlock Forecast - 30 Days FREE Trial $21M -5.3x 0.3x
CVKD Unlock Forecast - 30 Days FREE Trial $27M -11.1x 6.4x
CVSI Unlock Forecast - 30 Days FREE Trial $7M x 4.1x
CYDY Unlock Forecast - 30 Days FREE Trial $339M 86.7x x
CYRX Unlock Forecast - 30 Days FREE Trial $509M 6.8x 1.0x
CYTK Unlock Forecast - 30 Days FREE Trial $7M -9.4x -13.9x
DARE Unlock Forecast - 30 Days FREE Trial $18M 2.9x -2.3x
DAWN Unlock Forecast - 30 Days FREE Trial $738M -8.9x 1.6x
DERM Unlock Forecast - 30 Days FREE Trial $165M 24.1x 8.6x
DMAC Unlock Forecast - 30 Days FREE Trial $283M -4.2x 10.4x
DRMA Unlock Forecast - 30 Days FREE Trial $3M -0.2x 0.5x
DRRX Unlock Forecast - 30 Days FREE Trial $59M -1.2x 17.0x
DVAX Unlock Forecast - 30 Days FREE Trial $1150M 88.2x 2.3x
DWTX Unlock Forecast - 30 Days FREE Trial $11M -2.9x 1.6x
DYN Unlock Forecast - 30 Days FREE Trial $1871M -7.8x 3.3x
EBS Unlock Forecast - 30 Days FREE Trial $492M 3.5x 0.9x
ELAN Unlock Forecast - 30 Days FREE Trial $10191M 23.5x 1.5x
ELVN Unlock Forecast - 30 Days FREE Trial $1258M -13.3x 2.6x
ENLV Unlock Forecast - 30 Days FREE Trial $25M x 1.3x
ENTO Unlock Forecast - 30 Days FREE Trial $24M 0.0x 0.3x
EPIX Unlock Forecast - 30 Days FREE Trial $9M -2.7x 0.1x
ERAS Unlock Forecast - 30 Days FREE Trial $686M -3.1x 1.8x
ESPR Unlock Forecast - 30 Days FREE Trial $541M -4.2x -0.2x
ETNB Unlock Forecast - 30 Days FREE Trial $2193M -3.5x 4.2x
ETON Unlock Forecast - 30 Days FREE Trial $488M -66.2x 20.4x
EWTX Unlock Forecast - 30 Days FREE Trial $1636M -19.7x 2.8x
FBLG Unlock Forecast - 30 Days FREE Trial $15M x 17.6x
FGEN Unlock Forecast - 30 Days FREE Trial $42M -0.2x -3.6x
FHTX Unlock Forecast - 30 Days FREE Trial $223M -3.3x -5.5x
FLGC Unlock Forecast - 30 Days FREE Trial $406M -4.2x 101.0x
FOLD Unlock Forecast - 30 Days FREE Trial $2552M -8.5x 12.5x
FULC Unlock Forecast - 30 Days FREE Trial $486M -36.1x 2.3x
GALT Unlock Forecast - 30 Days FREE Trial $320M -2.4x -1.6x
GBIO Unlock Forecast - 30 Days FREE Trial $42M -0.6x 0.8x
GLMD Unlock Forecast - 30 Days FREE Trial $7M x 0.4x
GLSI Unlock Forecast - 30 Days FREE Trial $128M -17.2x 88.8x
GLTO Unlock Forecast - 30 Days FREE Trial $13M -2.5x 1.2x
GPCR Unlock Forecast - 30 Days FREE Trial $4851M -44.0x 6.3x
GRCE Unlock Forecast - 30 Days FREE Trial $43M -3.9x 0.7x
GRTX Unlock Forecast - 30 Days FREE Trial $1M -0.3x -0.1x
GYRE Unlock Forecast - 30 Days FREE Trial $754M 86.7x 8.2x
HCM Unlock Forecast - 30 Days FREE Trial $13429M x 10.9x
HMDCF Unlock Forecast - 30 Days FREE Trial $3194M x 2.6x
HOOK Unlock Forecast - 30 Days FREE Trial $11M -1.0x 0.3x
HOTH Unlock Forecast - 30 Days FREE Trial $19M -0.5x 1.9x
HOWL Unlock Forecast - 30 Days FREE Trial $73M -1.3x 1.8x
HRMY Unlock Forecast - 30 Days FREE Trial $1503M 8.3x 1.9x
HRTX Unlock Forecast - 30 Days FREE Trial $255M -6.4x -10.1x
IBIO Unlock Forecast - 30 Days FREE Trial $16M -0.4x 1.1x
IBO Unlock Forecast - 30 Days FREE Trial $7M x 6.5x
IGC Unlock Forecast - 30 Days FREE Trial $34M -4.6x 5.5x
IMNM Unlock Forecast - 30 Days FREE Trial $1340M -2.4x 5.0x
IMUC Unlock Forecast - 30 Days FREE Trial $4M x 1.1x
IMUX Unlock Forecast - 30 Days FREE Trial $79M -0.8x 2.3x
INDP Unlock Forecast - 30 Days FREE Trial $2M -0.6x 66.4x
INDV Unlock Forecast - 30 Days FREE Trial $3071M x x
INM Unlock Forecast - 30 Days FREE Trial $4M -51.8x 0.3x
INO Unlock Forecast - 30 Days FREE Trial $86M -0.6x 3.0x
INSM Unlock Forecast - 30 Days FREE Trial $34451M -14.0x 27.6x
INVA Unlock Forecast - 30 Days FREE Trial $1088M 28.2x 1.9x
IOBT Unlock Forecast - 30 Days FREE Trial $43M -0.7x 27.1x
IONS Unlock Forecast - 30 Days FREE Trial $11633M -14.6x 18.4x
IRD Unlock Forecast - 30 Days FREE Trial $112M -2.0x 6.4x
IRON Unlock Forecast - 30 Days FREE Trial $2574M -18.4x 4.2x
IRWD Unlock Forecast - 30 Days FREE Trial $232M 64.7x -0.4x
ISCO Unlock Forecast - 30 Days FREE Trial $1M x x
IXHL Unlock Forecast - 30 Days FREE Trial $6M x 0.8x
JANX Unlock Forecast - 30 Days FREE Trial $1531M -63.7x 1.6x
JAZZ Unlock Forecast - 30 Days FREE Trial $8201M 14.3x 2.2x
JBIO Unlock Forecast - 30 Days FREE Trial $306M x 1.5x
JNJ Unlock Forecast - 30 Days FREE Trial $465564M 20.6x 5.9x
JUNS Unlock Forecast - 30 Days FREE Trial $55M x 41.3x
KALA Unlock Forecast - 30 Days FREE Trial $9M -0.5x 6.5x
KAPA Unlock Forecast - 30 Days FREE Trial $21M x 3.4x
KPRX Unlock Forecast - 30 Days FREE Trial $9M -2.4x 0.4x
KPTI Unlock Forecast - 30 Days FREE Trial $51M -0.6x -0.2x
KURA Unlock Forecast - 30 Days FREE Trial $854M -4.5x 2.8x
KZR Unlock Forecast - 30 Days FREE Trial $47M -3.2x 0.5x
LEXX Unlock Forecast - 30 Days FREE Trial $16M -29.3x 2.9x
LIANY Unlock Forecast - 30 Days FREE Trial $7M x 0.0x
LIFD Unlock Forecast - 30 Days FREE Trial $4M x 0.1x
LIPO Unlock Forecast - 30 Days FREE Trial $3M -3.3x 1.0x
LLY Unlock Forecast - 30 Days FREE Trial $737606M 53.5x 40.4x
LQDA Unlock Forecast - 30 Days FREE Trial $2033M -7.2x 133.9x
LSTA Unlock Forecast - 30 Days FREE Trial $21M -1.0x 1.0x
LTRN Unlock Forecast - 30 Days FREE Trial $43M -2.4x 3.4x
LVTX Unlock Forecast - 30 Days FREE Trial $39M x 2.0x
LYEL Unlock Forecast - 30 Days FREE Trial $245M -1.1x 0.8x
MAIA Unlock Forecast - 30 Days FREE Trial $41M -1.4x 10.5x
MBIO Unlock Forecast - 30 Days FREE Trial $5M -0.1x 1.8x
MBX Unlock Forecast - 30 Days FREE Trial $443M x 2.0x
MDCX Unlock Forecast - 30 Days FREE Trial $38M x x
MDCXW Unlock Forecast - 30 Days FREE Trial $40M x x
MDGL Unlock Forecast - 30 Days FREE Trial $9825M -5.7x 14.1x
MGNX Unlock Forecast - 30 Days FREE Trial $104M -2.1x 2.2x
MIRA Unlock Forecast - 30 Days FREE Trial $28M -1.6x 49.4x
MIRM Unlock Forecast - 30 Days FREE Trial $3671M -20.0x 14.4x
MIST Unlock Forecast - 30 Days FREE Trial $104M -2.0x 4.2x
MLTX Unlock Forecast - 30 Days FREE Trial $577M -50.8x 1.6x
MLYS Unlock Forecast - 30 Days FREE Trial $2857M -4.5x 9.1x
MNKD Unlock Forecast - 30 Days FREE Trial $1619M 49.4x -20.2x
MRK Unlock Forecast - 30 Days FREE Trial $211646M 12.9x 4.3x
MRKR Unlock Forecast - 30 Days FREE Trial $12M -0.6x 1.1x
MRSN Unlock Forecast - 30 Days FREE Trial $49M -3.4x -1.4x
MRUS Unlock Forecast - 30 Days FREE Trial $7170M -13.5x 8.5x
MRVI Unlock Forecast - 30 Days FREE Trial $485M -5.6x 1.8x
MTSR Unlock Forecast - 30 Days FREE Trial $5545M x 12.3x
MTVA Unlock Forecast - 30 Days FREE Trial $24M -0.5x 2.5x
MURA Unlock Forecast - 30 Days FREE Trial $36M x 0.6x
NAMS Unlock Forecast - 30 Days FREE Trial $4080M x 5.2x
NAMSW Unlock Forecast - 30 Days FREE Trial $2773M x 3.6x
NATR Unlock Forecast - 30 Days FREE Trial $250M 17.7x 1.6x
NEUP Unlock Forecast - 30 Days FREE Trial $29M x 1.1x
NGNE Unlock Forecast - 30 Days FREE Trial $414M -7.3x 1.5x
NIKA Unlock Forecast - 30 Days FREE Trial $331M x x
NKTR Unlock Forecast - 30 Days FREE Trial $730M -1.2x 337.9x
NKTX Unlock Forecast - 30 Days FREE Trial $170M -1.3x 0.5x
NLSP Unlock Forecast - 30 Days FREE Trial $11M x 21.2x
NLSPW Unlock Forecast - 30 Days FREE Trial $0M x 0.3x
NRIX Unlock Forecast - 30 Days FREE Trial $756M -7.4x 2.0x
NRSN Unlock Forecast - 30 Days FREE Trial $29M x x
NTHI Unlock Forecast - 30 Days FREE Trial $197M x x
NUVL Unlock Forecast - 30 Days FREE Trial $6485M -30.9x 6.9x
NVCT Unlock Forecast - 30 Days FREE Trial $147M -3.9x 8.7x
NWBO Unlock Forecast - 30 Days FREE Trial $334M x x
NXEN Unlock Forecast - 30 Days FREE Trial $1M x x
OCEA Unlock Forecast - 30 Days FREE Trial $0M -0.3x 0.0x
OCUL Unlock Forecast - 30 Days FREE Trial $2002M -8.2x 6.6x
OGN Unlock Forecast - 30 Days FREE Trial $2420M 3.5x 3.3x
OKUR Unlock Forecast - 30 Days FREE Trial $37M -6.9x 0.5x
OLMA Unlock Forecast - 30 Days FREE Trial $642M -4.0x 1.9x
ONC Unlock Forecast - 30 Days FREE Trial $451912M x 119.9x
ORIC Unlock Forecast - 30 Days FREE Trial $1104M -4.2x 3.4x
OSTX Unlock Forecast - 30 Days FREE Trial $55M x 11.1x
OTLC Unlock Forecast - 30 Days FREE Trial $41M x 4.9x
OVID Unlock Forecast - 30 Days FREE Trial $105M -2.6x 1.9x
OWPC Unlock Forecast - 30 Days FREE Trial $2M x x
PAHC Unlock Forecast - 30 Days FREE Trial $1575M 32.6x 5.5x
PBH Unlock Forecast - 30 Days FREE Trial $3089M 14.5x 1.7x
PBYI Unlock Forecast - 30 Days FREE Trial $273M 5.6x 2.6x
PDSB Unlock Forecast - 30 Days FREE Trial $43M -1.7x 2.7x
PEPG Unlock Forecast - 30 Days FREE Trial $160M -1.6x 2.3x
PFE Unlock Forecast - 30 Days FREE Trial $138305M 12.9x 1.6x
PHAT Unlock Forecast - 30 Days FREE Trial $909M -1.6x -1.6x
PMHS Unlock Forecast - 30 Days FREE Trial $6M x 0.7x
PMN Unlock Forecast - 30 Days FREE Trial $14M -2.1x 2.1x
PMVP Unlock Forecast - 30 Days FREE Trial $74M -1.6x 0.5x
PPCB Unlock Forecast - 30 Days FREE Trial $18M x 1.0x
PRAX Unlock Forecast - 30 Days FREE Trial $3912M -4.0x 9.7x
PRFX Unlock Forecast - 30 Days FREE Trial $4M x x
PTCT Unlock Forecast - 30 Days FREE Trial $5304M 8.4x -20.3x
PTGX Unlock Forecast - 30 Days FREE Trial $4703M 90.4x 7.0x
PVCT Unlock Forecast - 30 Days FREE Trial $32M x x
QNRX Unlock Forecast - 30 Days FREE Trial $307M x 120.1x
RAPP Unlock Forecast - 30 Days FREE Trial $905M x 3.4x
REGN Unlock Forecast - 30 Days FREE Trial $62552M 14.0x 2.1x
REVB Unlock Forecast - 30 Days FREE Trial $2M -0.1x 0.5x
RFL Unlock Forecast - 30 Days FREE Trial $33M -0.9x 0.4x
RIGL Unlock Forecast - 30 Days FREE Trial $508M 5.2x 6.2x
RLYB Unlock Forecast - 30 Days FREE Trial $22M -0.7x 0.5x
RMTI Unlock Forecast - 30 Days FREE Trial $40M -17.1x 1.3x
RNA Unlock Forecast - 30 Days FREE Trial $5892M -12.2x 4.9x
RNAC Unlock Forecast - 30 Days FREE Trial $234M -2.1x -14.1x
RNAZ Unlock Forecast - 30 Days FREE Trial $13M -0.2x 2.1x
RNXT Unlock Forecast - 30 Days FREE Trial $41M -3.4x 3.9x
ROIV Unlock Forecast - 30 Days FREE Trial $11673M 1.8x 2.7x
RPRX Unlock Forecast - 30 Days FREE Trial $20720M 20.3x 3.3x
RPTX Unlock Forecast - 30 Days FREE Trial $79M -2.1x 0.7x
RTSL Unlock Forecast - 30 Days FREE Trial $0M 0.5x x
RVPH Unlock Forecast - 30 Days FREE Trial $39M -4.1x -4.3x
RYTM Unlock Forecast - 30 Days FREE Trial $7106M -20.3x 2603.1x
RZLT Unlock Forecast - 30 Days FREE Trial $752M -3.9x 4.6x
SAVA Unlock Forecast - 30 Days FREE Trial $208M -1.9x 2.4x
SCNX Unlock Forecast - 30 Days FREE Trial $9M 2.9x 0.1x
SCPH Unlock Forecast - 30 Days FREE Trial $302M -2.0x -50.9x
SCYX Unlock Forecast - 30 Days FREE Trial $30M -2.4x 0.7x
SDGR Unlock Forecast - 30 Days FREE Trial $1417M -7.8x 4.1x
SEPN Unlock Forecast - 30 Days FREE Trial $983M x 2.6x
SER Unlock Forecast - 30 Days FREE Trial $49M 22.6x 27.1x
SGMT Unlock Forecast - 30 Days FREE Trial $237M x 1.8x
SION Unlock Forecast - 30 Days FREE Trial $1421M x 4.2x
SKYE Unlock Forecast - 30 Days FREE Trial $43M -0.7x 1.0x
SLGL Unlock Forecast - 30 Days FREE Trial $113M x 3.6x
SLN Unlock Forecast - 30 Days FREE Trial $921M x 9.8x
SLNCF Unlock Forecast - 30 Days FREE Trial $227M x 2.4x
SNDX Unlock Forecast - 30 Days FREE Trial $1293M -4.1x 8.2x
SNNC Unlock Forecast - 30 Days FREE Trial $0M x x
SNSE Unlock Forecast - 30 Days FREE Trial $15M -0.4x 0.5x
SPRO Unlock Forecast - 30 Days FREE Trial $124M -17.8x 3.8x
SRPT Unlock Forecast - 30 Days FREE Trial $2301M 162.5x 1.7x
STOK Unlock Forecast - 30 Days FREE Trial $1821M 34.7x 5.4x
SUPN Unlock Forecast - 30 Days FREE Trial $2793M 43.3x 2.6x
SXTP Unlock Forecast - 30 Days FREE Trial $2M -0.6x 0.9x
SYBX Unlock Forecast - 30 Days FREE Trial $21M 3.6x 1.7x
TBPH Unlock Forecast - 30 Days FREE Trial $718M 55.1x 3.2x
TCRT Unlock Forecast - 30 Days FREE Trial $6M -1.0x 1.7x
TELO Unlock Forecast - 30 Days FREE Trial $48M x 99.6x
TERN Unlock Forecast - 30 Days FREE Trial $736M -5.1x 2.4x
TEVA Unlock Forecast - 30 Days FREE Trial $22751M -13.9x 3.3x
TEVJF Unlock Forecast - 30 Days FREE Trial $23192M x 3.4x
TGTX Unlock Forecast - 30 Days FREE Trial $5510M 91.1x 19.9x
TNGX Unlock Forecast - 30 Days FREE Trial $1009M -2.8x 7.5x
TNXP Unlock Forecast - 30 Days FREE Trial $141M 0.0x 0.8x
TOVX Unlock Forecast - 30 Days FREE Trial $4M -0.4x 0.1x
TRAW Unlock Forecast - 30 Days FREE Trial $20M -0.6x 1.8x
TRDA Unlock Forecast - 30 Days FREE Trial $223M 6.9x 0.6x
TRVI Unlock Forecast - 30 Days FREE Trial $1262M -6.1x 6.4x
TYRA Unlock Forecast - 30 Days FREE Trial $772M -9.5x 2.6x
UPB Unlock Forecast - 30 Days FREE Trial $1134M x 2.8x
URGN Unlock Forecast - 30 Days FREE Trial $782M -2.5x -15.2x
UTHR Unlock Forecast - 30 Days FREE Trial $19564M 15.8x 2.7x
VERA Unlock Forecast - 30 Days FREE Trial $1923M -20.4x 4.1x
VINC Unlock Forecast - 30 Days FREE Trial $0M -0.2x 0.1x
VNDA Unlock Forecast - 30 Days FREE Trial $311M -16.1x 0.6x
VRCA Unlock Forecast - 30 Days FREE Trial $38M -0.5x -4.1x
VREOF Unlock Forecast - 30 Days FREE Trial $317M x 1.2x
VRNA Unlock Forecast - 30 Days FREE Trial $73547M -185.1x 264.3x
VRTX Unlock Forecast - 30 Days FREE Trial $104724M 28.8x 6.1x
VTGN Unlock Forecast - 30 Days FREE Trial $129M -0.1x 2.3x
VTRS Unlock Forecast - 30 Days FREE Trial $11945M -29.5x 0.0x
VTVT Unlock Forecast - 30 Days FREE Trial $0M -3.3x -7.5x
VTYX Unlock Forecast - 30 Days FREE Trial $279M -1.0x 1.3x
VYNE Unlock Forecast - 30 Days FREE Trial $7M -0.4x 0.2x
WHWK Unlock Forecast - 30 Days FREE Trial $104M x 0.6x
XBIT Unlock Forecast - 30 Days FREE Trial $76M -3.5x 0.4x
XERS Unlock Forecast - 30 Days FREE Trial $1499M 388.5x -23.8x
XLO Unlock Forecast - 30 Days FREE Trial $39M -0.5x 5.5x
XOMA Unlock Forecast - 30 Days FREE Trial $418M -11.7x 5.8x
XOMAO Unlock Forecast - 30 Days FREE Trial $305M -10.1x 4.2x
XOMAP Unlock Forecast - 30 Days FREE Trial $320M -10.5x 4.4x
ZBIO Unlock Forecast - 30 Days FREE Trial $1008M x 4.2x
ZLAB Unlock Forecast - 30 Days FREE Trial $31698M -95.2x 40.0x
ZOMDF Unlock Forecast - 30 Days FREE Trial $62M x 0.5x
ZTS Unlock Forecast - 30 Days FREE Trial $63600M 24.4x 12.8x
ZYME Unlock Forecast - 30 Days FREE Trial $1378M -8.3x 4.1x

Frequently Asked Questions - ARROWHEAD PHARMACEUTICALS, INC. Stock Forecast

How accurate are ARROWHEAD PHARMACEUTICALS, INC. stock predictions?

Our AI model demonstrates 62% historical accuracy for ARWR predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence ARROWHEAD PHARMACEUTICALS, INC. stock price forecasts?

Our analysis considers ARROWHEAD PHARMACEUTICALS, INC.'s financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is ARROWHEAD PHARMACEUTICALS, INC. a good investment in 2025?

Based on our AI analysis, ARROWHEAD PHARMACEUTICALS, INC. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are ARROWHEAD PHARMACEUTICALS, INC. forecasts updated?

ARROWHEAD PHARMACEUTICALS, INC. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced ARROWHEAD PHARMACEUTICALS, INC. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for ARROWHEAD PHARMACEUTICALS, INC. stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...